Drug compounding firm PharMEDium in $1 bln sale talks

VC-backed company in talks with buyers, including TPG Capital, about a deal

19 November 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.